Mangaluru Airport to go silent from January 2018

coastaldigest.com news network
December 23, 2017

Mangaluru, Dec 23: The Mangaluru International Airport is all set to become a 'silent airport'. With this, the regular announcements of flight departure and arrival will be stopped, said sources said.

A press release said that no announcements will be made at the terminal building effective from January 2. However, special care will be taken care for "Divyang" passengers (Orthopaedically handicapped/Paraplegic and Mentally retarded persons) by the concerned Airlines.

With this passengers will have to rely mainly on display boards at the airport and messages sent by the respective airlines.

Meanwhile, on the direction of Bureau of Civil Aviation Security, New Delhi, Mangaluru International Airport has also become free from stamping of hand baggage tags at pre-embarkation security check points.

Comments

Danish
 - 
Saturday, 23 Dec 2017

What about free help desk for filling forms an all?

Ganesh
 - 
Saturday, 23 Dec 2017

Similarly Mangalore Airport should be more passenger friendly

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 12,2020

Bengaluru, May 12: Chief Minister B S Yediyurappa had promised to extend all co-operation for the safe and early return of the Karnataka ex-pats, living in the United Arab Emirates (UAE), here on Tuesday.

He was speaking to the Karnataka ex-pats living in UAE, who had pleaded the chief minister to make arrangements for their return to the state.

Those who had spoken to the Chief Minister had informed that there is a large number of people, landed into a great difficulty ever since the onset of the COVID-19 pandemic and eager to return to their home state, Karnataka.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 27,2020

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 2,2020

Kasaragod, Apr 2: Kerala reported 21 new cases of coronavirus with eight from the worst affected Kasaragod district, taking the tally of active patients to 256, Chief Minister Pinarayi Vijayan said on Thursday.

Besides, Kasaragod, five positive cases have been detected from Idukki, two from Kollam and one each from Thiruvananthapuram, Pathnamthitta, Thrissur, Malappuram, Kozhikode and Kannur, he told reporters here.

At least 1.65 lakh people are under survillence in the state, 643 in various hospitals.

Presently, 256 people are under treatment for the virus in the state where two fatalities have occurred, Vijayan said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.